Small molecule composition for partial reprogramming of pig somatic cells, partial reprogramming nuclear donor cell and application of partial reprogramming nuclear donor cell
By screening small molecule combinations of CHIR99021, Repsox-616452, TTNPB, and SAG suitable for porcine "3+X" gene-edited cells, partial reprogramming was performed, solving the problem of deterioration in nuclear donor cell quality and achieving efficient and safe nuclear donor cell preparation, significantly reducing early abortion rate and improving production efficiency.
Patent Information
- Application Number
- CN202610436499.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-04-02
- Publication Date
- 2026-06-05
AI Technical Summary
Existing small molecule reprogramming technology cannot effectively improve the quality of "3+X" gene-edited pig somatic cells, leading to nuclear donor cell aging and incomplete nuclear reprogramming, which in turn causes problems such as embryo implantation failure and high early miscarriage rates. Furthermore, it suffers from species-specific barriers, lack of targeted protocols, and uncontrollable safety.
Using a small molecule composition of CHIR99021, Repsox-616452, TTNPB and SAG, at specific concentrations and ratios, porcine "3+X" gene-edited cells were partially reprogrammed to reverse their aging-related phenotypic and functional states, thus producing high-quality nuclear donor cells.
It significantly reduced the early abortion rate to below 10%, improved the clonal expansion potential and production efficiency of cells, solved the bottleneck in the preparation of a moderate number of genetically modified donor pigs, and achieved a high pregnancy maintenance rate and healthy farrowing rate.